Lantheus Holdings, Inc. Business Combination, Contingent Consideration, Liability
Lantheus Holdings, Inc. (LNTH) had Business Combination, Contingent Consideration, Liability of $65.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2026-08-06
- 2026-06-30: Business Combination, Contingent Consideration, Liability $65.04M.
- 2026-03-31: Business Combination, Contingent Consideration, Liability $93.98M.
- 2025-12-31: Business Combination, Contingent Consideration, Liability $94.34M.
- 2025-09-30: Business Combination, Contingent Consideration, Liability $97.82M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2026-06-30 | $65.04M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $93.98M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $94.34M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $97.82M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $43.04M 10-Q · filed 2025-08-06 |
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2024-09-30 | $1.29M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $2.80M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $2.70M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $2.70M 10-K · filed 2025-02-26 |
| 2023-09-30 | $2.50M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.00M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $110.20M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $111.60M 10-K · filed 2024-02-22 |
| 2022-09-30 | $110.50M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $111.50M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $104.20M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $86.20M 10-K · filed 2023-02-23 |
| 2021-09-30 | $46.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $43.80M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $17.00M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $15.80M 10-K · filed 2022-02-24 |
| 2020-09-30 | $17.20M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $16.30M 10-Q · filed 2020-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |